CJC-1295 (WITHOUT DAC) + IPAMORELIN

CJC-1295 without DAC and Ipamorelin are studied for their effects on growth hormone signaling through different pathways. DeSoto Peptides supplies them together as a lyophilized research blend and is developing batch-specific documentation to support verification of its research materials.

Illustration of a small medicine vial or vial with a blue cross symbol on it.

10MG PER VIAL

Lyophilized research material

Digital illustration of a microscope with blue and white highlights.

RESEARCH GRADE

Lot-specific documentation available

A shield with a check mark symbol in the center, representing security or protection.

BATCH VERIFIED

For laboratory research only

TWO PEPTIDES. DISTINCT SIGNALING PATHWAYS.

CJC-1295 without DAC is a growth hormone–releasing hormone (GHRH) analog. Ipamorelin is a growth hormone secretagogue studied through a different receptor pathway. Research on these pathways examines how each can stimulate growth hormone release. Findings from either component alone should not be presented as results for the combined blend.

A digital illustration of a DNA molecule with a ribbon structure, under a black background. Text above reads 'CJC-1295 Without DAC' in blue and white.

GHRH receptor signaling
Pituitary research

Digital illustration of a molecular structure with a purple ribbon strand, labeled 'IPAMORELIN' in purple text at the top, against a black background.

Growth hormone secretagogue signaling
Pituitary research

Illustration of a green ribbon-like protein structure with atom models, with the text 'GROWTH HORMONE' in glowing green letters at the top.

Hormone releasing agent
Downstream signaling

WHAT THE RESEARCH SHOWS

Research has examined how GHRH analogs and Ipamorelin affect growth hormone release through different signaling pathways. In a small human study, Ipamorelin produced a measurable rise in growth hormone after infusion.

A neon sign displaying research information about growth hormone signaling, with a black background, with text about research pathways, related GHRH analogs, and Ipamorelin, including additional study details at the bottom.

The studies cited here examine individual peptides or related pathways; they do not measure the effects of this specific CJC-1295 without DAC + Ipamorelin blend.

Neon sign displaying 0.67 hours for Pmorelin GH peak, reported in human volunteer research.

Neon sign with text '5 Dose Levels, Ipamorelin Human Study, 8 volunteers at each dose level' in blue and white on a black background.

Neon sign with black background reading: "PEER-REVIEWED RESEARCH, Pharm Res. 1999, Ipamorelin human volunteer study."

Screen displaying a scholarly citation in white text on a black background, titled 'CITED STUDIES' with a neon blue border.

CJC-1295 + Ipamorelin 10MG

Research material with batch-specific documentation.

Learn More About CJC/IPA

Contact Us

For research use only. Not for human consumption